DrugPatentWatch Database Preview➤ Subscribe for complete access
« Back to Dashboard
Summary for Patent: 6,201,105
|Title:||Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)|
|Abstract:||Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.|
|Inventor(s):||Smith; Craig A. (Seattle, WA), Goodwin; Raymond G. (Seattle, WA), Beckmann; M. Patricia (Poulsbo, WA)|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for patent 6,201,105|
|Patent Claims:||1. A recombinant protein comprising amino acids 1-163 of FIGS. 2A-2B, and wherein said recombinant protein binds TNF.
2. The recombinant protein of claim 1, wherein said protein comprises amino acids 1-185 of FIGS. 2A-2B.
3. The recombinant protein of claim 1, wherein said protein comprises amino acids 1-235 of FIGS. 2A-2C.
4. The recombinant protein of claim 1, wherein said extracellular region does not have native-pattern glycosylation.
|Applicant||Tradename||Biologic Ingredient||Dosage Form||BLA||Approval Date||Patent No.||Expiredate|
|Immunex Corporation||ENBREL||etanercept||For Injection||103795||1998-11-02||⤷ Free Forever Trial||2009-09-05|
|Immunex Corporation||ENBREL||etanercept||For Injection||103795||1999-05-27||⤷ Free Forever Trial||2009-09-05|
|Immunex Corporation||ENBREL||etanercept||Injection||103795||2004-09-27||⤷ Free Forever Trial||2009-09-05|
|Immunex Corporation||ENBREL||etanercept||Injection||103795||2007-02-01||⤷ Free Forever Trial||2009-09-05|
|Immunex Corporation||ENBREL MINI||etanercept||Injection||103795||2017-09-14||⤷ Free Forever Trial||2009-09-05|
|Immunex Corporation||ENBREL||etanercept||Injection||103795||⤷ Free Forever Trial||2009-09-05|
|>Applicant||>Tradename||>Biologic Ingredient||>Dosage Form||>BLA||>Approval Date||>Patent No.||>Expiredate|
|Country||Patent Number||Estimated Expiration|
|Austria||131871||⤷ Free Forever Trial|
|Austria||242322||⤷ Free Forever Trial|
|Australia||3970293||⤷ Free Forever Trial|
|Australia||4920993||⤷ Free Forever Trial|
|Australia||6178190||⤷ Free Forever Trial|
|Australia||630497||⤷ Free Forever Trial|
|>Country||>Patent Number||>Estimated Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.